HIV Policy & Advocacy
FDA Reduces Gay Blood Donation Ban to 1 Year After Sex, Critics Say It's Still Discriminatory
- Details
- Category: HIV Policy & Advocacy
- Published on Tuesday, 19 May 2015 00:00
- Written by Liz Highleyman
On May 12 the U.S. Food and Drug Administration (FDA) issued draft guidance stating that men who have sex with men should wait to donate blood until 12 months after their last sexual contact with another man. This is an improvement over the previous policy of lifetime deferral, but some advocates argue that the new regulations still discriminate against gay and bisexual men.
BHIVA 2015: HIV Treatment Outcomes No Better with Single-tablet Regimens than Individual Pills
- Details
- Category: Drug Pricing & Patents
- Published on Thursday, 23 April 2015 00:00
- Written by Roger Pebody
One-pill-a-day HIV treatments such as Atripla, Stribild, Complera, and Triumeq and Triumeq have the same rates of virological failure, drug resistance, and side effects as multiple tablet regimens, according to a meta-analysis presented to the British HIV Association (BHIVA) conference this week in Brighton. Single tablets cost the UK National Health Service (NHS) 5 five times more but have unproven clinical benefits, said Andrew Hill of Chelsea and Westminster Hospital.
San Francisco Stakeholders Flesh Out 'Getting to Zero' HIV Plan
- Details
- Category: HIV Policy & Advocacy
- Published on Thursday, 29 January 2015 00:00
- Written by Liz Highleyman
Public health officials, healthcare providers, and community advocates provided more details and raised more questions about San Francisco's Getting to Zero plan for eliminating new HIV infections at a recent Board of Supervisors hearing. Attendees emphasized that funding for the new initiative should not come at the expense of existing HIV services.
Obama Budget Boosts U.S. HIV and Hepatitis Funding, Cuts Global AIDS and TB
- Details
- Category: HIV Policy & Advocacy
- Published on Thursday, 05 February 2015 00:00
- Written by Liz Highleyman
President Obama's proposed $4 trillion budget for fiscal year 2016 would increase funding for CDC's viral hepatitis and HIV prevention efforts, boost spending for HIV research, and allocate more to combat antibiotic resistance. The proposal would also change the law to allow Medicare to negotiate prescription drug prices, which could potentially save billions of dollars. But the plan would cut overall global health funding, including support for the Global Fund to Fight AIDS, Malaria, and Tuberculosis.
Obamacare Deadline Coming Up, Guide Offers Covered California Advice for HIV, HCV, PrEP
- Details
- Category: HIV Policy & Advocacy
- Published on Thursday, 11 December 2014 00:00
- Written by HIVandHepatitis.com
December 15 is the deadline to enroll in Affordable Care Act (ACA or "Obamacare") health plans for insurance coverage starting on January 1, 2015. Finding the right plan can be tricky for people with HIV or hepatitis C, and for those who want coverage for Truvada for pre-exposure prophylaxis (PrEP), but there are resources to help.
Web Design and Development by